Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Safety and Effectiveness of the Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes

NCT04617795 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT04617795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04617795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Safety and Effectiveness of the Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes
Lead sponsor
Insulet Corporation
Phase
Not applicable
Overall status
Completed
Start date
November 23, 2020
Completion date
March 6, 2022
Enrollment
25 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus